| Literature DB >> 35024669 |
Jiangfeng Ye1, Yan Chen2, Hua Yang3, Qian Chen4, Yun Huang4, Jian Zhao4, Lei Tu5, Ming Liu6, Jun Zhang4.
Abstract
BACKGROUND: A restrictive use of episiotomy was recommended by the obstetric society in China, but limited information on the epidemiology and the effects of restrictive use of episiotomy on maternal and fetal outcomes have been published.Entities:
Keywords: China; epidemiology; episiotomy; maternal outcome; neonatal outcome
Year: 2021 PMID: 35024669 PMCID: PMC8671730 DOI: 10.1016/j.lanwpc.2021.100345
Source DB: PubMed Journal: Lancet Reg Health West Pac ISSN: 2666-6065
Figure 1Study flow chart
Distribution of characteristics and the associations with episiotomy among primiparae and multiparae, China, 2015-2016
| Hospital class | |||||||||
| Secondary hospital | 50·0 | 40·8 | Ref | 63·8 | 23·1 | Ref | |||
| Tertiary hospital | 50·0 | 42·6 | 0·98 (0·43, 2·26) | 36·2 | 18·5 | 0·90 (0·41, 1·97) | |||
| Hospital annual delivery number | |||||||||
| <5000 | 44·7 | 49·3 | Ref | 57·3 | 28·6 | Ref | |||
| 5000-10000 | 33·5 | 37·6 | 0·74 (0·41, 1·33) | 29·9 | 14·8 | 0·81 (0·46, 1·42) | |||
| >10000 | 21·8 | 32·3 | 12·8 | 5·0 | |||||
| Hospital type | |||||||||
| General hospital | 41·7 | 48·9 | Ref | 56·6 | 30·3 | Ref | |||
| Maternity hospital | 58·3 | 36·5 | 0·54 (0·21, 1·39) | 43·4 | 10·0 | 0·40 (0·16, 1·00) | |||
| Maternal age (year) | |||||||||
| < 35 | 97·8 | 41·5 | Ref | 85·8 | 22·3 | Ref | |||
| ≥ 35 | 2·2 | 48·0 | 1·38 (1·35, 1·41) | 14·2 | 16·1 | 1·08 (1·06, 1·09) | |||
| Maternal education | |||||||||
| Low | 20·6 | 39·6 | 0·85 (0·84, 0·85) | 45·5 | 23·6 | 1·05 (1·04, 1·07) | |||
| Middle | 39·4 | 41·9 | Ref | 31·7 | 18·7 | Ref | |||
| High | 31·0 | 40·2 | 0·98 (0·97, 0·99) | 14·6 | 16·1 | 2·92 (2·86, 2·99) | |||
| Insurance | |||||||||
| Yes | 64·5 | 42·9 | Ref | 52·7 | 24·0 | Ref | |||
| No | 32·8 | 38·5 | 0·93 (0·92, 0·93) | 44·6 | 17·5 | 1·18 (1·16, 1·19) | |||
| Prepregnancy BMI | |||||||||
| < 18·5 kg/m2 | 12·5 | 42·0 | 0·86 (0·85, 0·87) | 8·5 | 29·6 | 1·48 (1·46, 1·50) | 1·48 (1·45, 1·50) | ||
| 18·5-24·9 kg/m2 | 53·4 | 40·5 | Ref | 49·6 | 18·5 | Ref | Ref | ||
| ≥ 25 kg/m2 | 6·4 | 43·8 | 0·94 (0·93, 0·95) | 8·4 | 14·3 | 0·87 (0·86, 0·89) | 0·90 (0·89, 0·92) | ||
| Previous caesarean section | |||||||||
| No | - | - | - | 94·2 | 20·1 | Ref | Ref | ||
| Yes | - | - | - | 5·8 | 43·0 | 5·56 (5·46, 5·66) | 5·39 (5·30, 5·49) | ||
| Assisted reproductive technology | |||||||||
| No | 94·6 | 41·1 | Ref | Ref | 92·9 | 20·5 | Ref | Ref | |
| Yes | 5·2 | 51·2 | 1·51 (1·49, 1·54) | 1·55 (1·52, 1·57) | 6·9 | 34·3 | 1·76 (1·72, 1·79) | 1·84 (1·81, 1·88) | |
| Multiple pregnancy | |||||||||
| No | 99·5 | 41·7 | Ref | 99·2 | 21·5 | Ref | |||
| Yes | 0·5 | 38·5 | 1·18 (1·12, 1·24) | 0·8 | 13·3 | 1·73 (1·63, 1·83) | |||
| Maternal disease | |||||||||
| No | 79·7 | 41·9 | - | 78·1 | 23·6 | - | |||
| Yes | - | - | |||||||
| Hypertensive disordersc | 2·4 | 46·1 | 1·55 (1·52, 1·58) | 1·9 | 19·9 | 1·44 (1·40, 1·49) | |||
| Diabetes mellitusd | 10·3 | 41·1 | 1·13 (1·12, 1·15) | 8·8 | 15·4 | 1·21 (1·19, 1·23) | 1·22 (1·20, 1·24) | ||
| Thyroid diseases | 3·4 | 46·6 | 0·99 (0·97, 1·01) | 2·1 | 15·3 | 0·60 (0·58, 0·62) | |||
| Cardiac diseases | 0·2 | 17·5 | 0·25 (0·23, 0·27) | 0·1 | 24·1 | 1·54 (1·37, 1·73) | 1·56 (1·39, 1·76) | ||
| Kidney diseases | 0·1 | 61·2 | 1·87 (1·65, 2·12) | 0·03 | 24·2 | 1·39 (1·10, 1·75) | 1·49 (1·19, 1·88) | ||
| Asthma | 0·1 | 41·3 | 1·25 (1·14, 1·38) | 0·04 | 9·3 | 0·52 (0·40, 0·68) | 0·49 (0·38, 0·63) | ||
| Disorder of immune system | 0·1 | 47·9 | 0·85 (0·78, 0·93) | 0·1 | 11·2 | 0·50 (0·43, 0·58) | 0·46 (0·40, 0·53) | ||
| Sexually transmitted diseases | 0·8 | 27·9 | 0·74 (0·71, 0·77) | 0·70 (0·67, 0·73) | 0·5 | 12·0 | 0·94 (0·88, 1·01) | 1·00 (0·94, 1·08) | |
| Placenta previa | |||||||||
| No | 99·7 | 41·7 | Ref | Ref | 99·8 | 21·5 | Ref | Ref | |
| Yes | 0·3 | 15·8 | 0·31 (0·29, 0·34) | 0·29 (0·27, 0·32) | 0·2 | 2·0 | 0·09 (0·07, 0·11) | 0·09 (0·07, 0·11) | |
| Placenta abruption | |||||||||
| No | 99·6 | 41·7 | Ref | 99·3 | 21·5 | Ref | Ref | ||
| Yes | 0·3 | 40·5 | 0·83 (0·78, 0·88) | 0·6 | 12·1 | 0·42 (0·39, 0·45) | 0·42 (0·39, 0·45) | ||
| Premature rupture of fetal membranes | |||||||||
| No | 84·4 | 41·7 | Ref | Ref | 86·5 | 20·5 | Ref | Ref | |
| Yes | 15·6 | 41·3 | 1·00 (0·99, 1·01) | 1·01 (1·00, 1·02) | 13·2 | 26·9 | 1·31 (1·30, 1·33) | 1·32 (1·31, 1·34) | |
| Unknown | 0·1 | 60·9 | 4·95 (4·07, 6·02) | 6·04 (5·00, 7·31) | 0·3 | 55·2 | 8·40 (7·76, 9·09) | 9·03 (8·35, 9·77) | |
| Presentation | |||||||||
| Vertex presentation | 99·4 | 41·8 | Ref | 98·9 | 21·5 | Ref | |||
| Breech presentation and others | 0·5 | 28·4 | 0·43 (0·40, 0·45)f | 0·8 | 18·5 | 0·98 (0·93, 1·04) | |||
| Onset of labour | |||||||||
| Spontaneous | 79·5 | 41·5 | Ref | 84·7 | 21·4 | Ref | |||
| Induced | 20·0 | 42·3 | 0·94 (0·93, 0·95) | 14·9 | 22·2 | 0·90 (0·89, 0·91) | |||
| Augmentation | |||||||||
| No | 75·4 | 40·3 | Ref | 84·6 | 20·3 | Ref | |||
| Yes | 24·0 | 46·2 | 1·26 (1·25, 1·27) | 15·1 | 28·2 | 1·19 (1·18, 1·21) | |||
| Anesthesia or analgesia | |||||||||
| No | 63·1 | 42·0 | Ref | Ref | 78·1 | 21·9 | Ref | Ref | |
| Yes | 34·7 | 41·3 | 1·25 (1·24, 1·26) | 1·30 (1·29, 1·31) | 19·7 | 20·8 | 2·19 (2·16, 2·22) | 2·18 (2·15, 2·21) | |
| Mode of delivery | |||||||||
| Spontaneous | 96·8 | 40·1 | Ref | Ref | 98·9 | 20·9 | Ref | Ref | |
| Forceps | 2·1 | 89·6 | 9·86 (9·51, 10·22) | 10·27 (9·91, 10·65) | 0·5 | 84·3 | 35·51 (33·07, 38·13) | 33·89 (31·59, 36·36) | |
| Vacuum-assisted | 0·6 | 96·4 | 51·92 (46·88, 57·51) | 48·23 (43·56, 53·40) | 0·4 | 89·2 | 17·62 (16·10, 19·28) | 17·65 (16·13, 19·32) | |
| Prolonged second stage of labore | |||||||||
| No | 87·9 | 39·5 | Ref | Ref | 85·9 | 18·6 | Ref | Ref | |
| Yes | 10·2 | 63·8 | 3·38 (3·34, 3·41) | 3·48 (3·44, 3·52) | 10·8 | 47·4 | 4·27 (4·22, 4·33) | 4·28 (4·23, 4·33) | |
| Fetal distress | |||||||||
| No | 95·7 | 39·9 | Ref | Ref | 98·0 | 21·1 | Ref | Ref | |
| Yes | 4·1 | 82·4 | 8·09 (7·92, 8·26) | 7·93 (7·77, 8·10) | 1·8 | 41·0 | 2·36 (2·28, 2·43) | 2·41 (2·34, 2·49) | |
| Gestational age at birth | |||||||||
| Preterm | 6·3 | 38·2 | 1·03 (1·02, 1·04) | 0·99 (0·97, 1·00) | 6·7 | 17·1 | 0·62 (0·61, 0·63) | 0·62 (0·61, 0·64) | |
| Term | 92·4 | 41·9 | Ref | Ref | 90·8 | 21·7 | Ref | Ref | |
| Postterm | 0·3 | 54·8 | 0·70 (0·65, 0·74) | 0·66 (0·62, 0·71) | 0·4 | 21·5 | 1·26 (1·18, 1·34) | 1·26 (1·18, 1·34) | |
| Birth weight | |||||||||
| < 4000 g | 94·7 | 41·5 | Ref | Ref | 92·5 | 21·7 | Ref | Ref | |
| ≥ 4000 g | 3·7 | 52·7 | 2·11 (2·08, 2·15) | 2·09 (2·06, 2·13) | 5·6 | 20·8 | 1·33 (1·31, 1·36) | 1·35 (1·33, 1·38) | |
a: Percentages may not sum to 100 due to missing values. Less than 10% of data for each variable was missing, except for BMI (23.4%). We included missing categories for all regression analyses.
b: Model 1: model with all covariates listed. Model 2: model with selected covariates.
c: Hypertensive disorders includes chronic hypertension, gestational hypertension, preeclampsia, and eclampsia.
d: Diabetes includes pre-existing and gestational diabetes mellitus.
e: Prolonged second stage of labor is defined as: the duration of second stage of labor is > 2 hours for the primiparae or > 1 hour for the multiparae.
f: 90% of the births were diagnosed to be born through vaginal delivery at the in-hospital labor diagnosis.
Figure 2Episiotomy rate (weighted) by location, China, 2015-2016 (A Primiparae; B Multiparae)
Figure 3Episiotomy rate at hospital level by parity, China, 2015-2016 (A Primiparae; B Multiparae)
Distribution of the top five medical conditions among clusters of conditions associated with the use of episiotomy, China, 2015-2016
| Total (number, %) | 330933 (35·0) | 229906 (24·3) | 207471 (22·0) | 176385 (18·7) | 165004 (34·9) | 123519 (26·2) | 96884 (20·5) | 86903 (18·4) | |
| Medical conditions (%) | None (100·0) | Prolonged second stage of labor (59·6) | Premature rupture of fetal membranes (57·1) | Anesthesia or analgesia (100·0) | Prolonged second stage of labor (43·1) | None (100·0) | Premature rupture of fetal membranes (56·0) | Maternal disease (60·1) | |
| Anesthesia or analgesia (37·2) | Anesthesia or analgesia (30·3) | Anesthesia or analgesia (36·0) | Previous caesarean section (48·8) | Prolonged second stage of labor (30·4) | |||||
| Fetal distress (29·1) | Assisted reproductive technology (29·0) | Assisted reproductive technology (31·4) | Gestational age (23·7) | Birth weight (27·9) | |||||
| Mode of delivery (21·6) | Gestational age (28·1) | Prepregnancy BMI (29·4) | Prolonged second stage of labor (15·9) | Anesthesia or analgesia (21·8) | |||||
| Birth weight (18·6) | Prolonged second stage of labor (4·8) | Premature rupture of fetal membranes (4·5) | Anesthesia or analgesia (12·2) | Premature rupture of fetal membranes (18·9) | |||||
a Average Silhouette=0·6 and 0·3 in the primiparae and multiparae, respectively.
Relationship between mediolateral episiotomy and severe maternal and neonatal adverse outcomes in the propensity score matched sample of women without medical conditions associated with the use of episiotomy, China, 2015-2016
| Maternal outcomes | 633 (5·7) | 248 (4·8) | 1·08 (0·89, 1·30) | 197 (4·9) | 11 (3·3) | 0·65 (0·28, 1·53) | |
| Third- or fourth- degree perineal laceration | 7 (0·06) | 19 (0·4) | 2·64 (1·08, 6·48) | 0 (0·0) | 2 (0·6) | - | |
| Second-degree perineal laceration | 1661 (15.1) | 100 (1.9) | 0.10 (0.08, 0.13) | 578 (14.5) | 8 (2.4) | 0.13 (0.06, 0.29) | |
| Postpartum haemorrhage | 614 (5·6) | 223 (4·3) | 1·02 (0·83, 1·24) | 196 (4·9) | 9 (2·7) | 0·51 (0·20, 1·29) | |
| Admission to ICU, referral to a higher level hospital, ≥ 7 days postnatal hospitalization, or death | 14 (0·13) | 8 (0·16) | 1·30 (0·44, 3·82) | 2 (0·05) | 0 (0·0) | - | |
| Neonatal outcome | |||||||
| Apgar score at 5 minutes < 4 | 25 (0·23) | 6 (0·12) | 0·48 (0·17, 1·32) | 5 (0·1) | 1 (0·3) | 5·99 (0·03, >999) | |